stockrowAmphastar Pharmaceuticals, Inc. (AMPH) vs Cronos Group Inc. (CRON)
- Amphastar Pharmaceuticals, Inc. AMPH 28.45 +2.86%
- Cronos Group Inc. CRON 3.61 −2.96%
Amphastar Pharmaceuticals, Inc. and Cronos Group Inc. are both Drug Manufacturers Specialty & Generic companies. Cronos Group Inc. is the larger, with a market value of $1.4B against $1.2B — 1.2× the size. Amphastar Pharmaceuticals, Inc. trades at the lower P/E: 12.3× against 21.9×. Cronos Group Inc. grew revenue faster over the last twelve months: 55.8% against 3.11%. Cronos Group Inc. has the higher net margin (28.0% vs 13.3%) and the lower return on invested capital (1.28% vs 6.12%). Across the 22 metrics below, Amphastar Pharmaceuticals, Inc. leads on 15 and Cronos Group Inc. on 7.
Valuation
Profitability
| Metric | AMPH | CRON | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 46.81% | 46.59% | 53.51% |
| Operating margin | 18.74% | 3.78% | 0.00% |
| Net margin | 13.27% | 28.04% | (2.45%) |
| Free cash flow margin | 18.64% | 31.71% | 0.00% |
| Return on equity | 12.44% | 5.12% | (0.80%) |
| Return on assets | 5.86% | 4.87% | (1.67%) |
| Return on invested capital | 6.12% | 1.28% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack